Patents by Inventor Victor J. Bauer

Victor J. Bauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR ORAL DELIVERY OF FTS
    Publication number: 20160271089
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Application
    Filed: June 1, 2016
    Publication date: September 22, 2016
    Applicant: Kadmon Corporation, LLC
    Inventor: Victor J. Bauer
  • METHODS AND COMPOSITIONS FOR ORAL DELIVERY OF FTS
    Publication number: 20150191426
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Application
    Filed: March 19, 2015
    Publication date: July 9, 2015
    Inventor: Victor J. Bauer
  • Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer
    Patent number: 8338481
    Abstract: Disclosed are alkoxyalkyl S-prenylthiosalicylates and pharmaceutical compositions containing the same and a pharmaceutically acceptable carrier. Methods for treating a human afflicted with cancer, including solid tumors, or a hematological malignancy by administering to the human in need thereof an effective amount of an alkoxyalkyl S-prenylthiosalicylate are also disclosed.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: December 25, 2012
    Assignees: Ramot at Tel-Aviv University Ltd., Kadmon Corporation, LLC
    Inventors: Yoel Kloog, Liat Goldberg, Victor J. Bauer
  • METHODS AND COMPOSITIONS FOR ORAL DELIVERY OF FTS
    Publication number: 20120082722
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Application
    Filed: December 15, 2011
    Publication date: April 5, 2012
    Applicant: CONCORDIA PHARMACEUTICALS, INC.
    Inventor: Victor J. Bauer
  • Methods and compositions for oral delivery of FTS
    Patent number: 8088756
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Grant
    Filed: August 18, 2005
    Date of Patent: January 3, 2012
    Assignee: Concordia Pharmaceuticals, Inc.
    Inventor: Victor J. Bauer
  • (Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases
    Patent number: 8058437
    Abstract: A novel co-crystal of N?-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid is disclosed. The disclosed oxalic acid co-crystal demonstrates cancer cell growth inhibition and is more bioavailable than the corresponding free base when administered as a suspension.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: November 15, 2011
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Victor J Bauer, Mike H O'Neill, Barbara J Kidon, Burkhard Jansen
  • NOVEL (PYRROLOQUINOXALINYL) PYRAZINECARBOHYDRAZIDE-OXALIC ACID CO-CRYSTAL FOR TREATMENT OF CANCER AND OTHER DISEASES
    Publication number: 20110034473
    Abstract: A novel co-crystal of N?-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid is disclosed. The disclosed oxalic acid co-crystal demonstrates cancer cell growth inhibition and is more bioavailable than the corresponding free base when administered as a suspension.
    Type: Application
    Filed: April 8, 2009
    Publication date: February 10, 2011
    Applicant: NOVELIX PHARMACEUTICALS, INC.
    Inventors: Victor J. Bauer, Mike H. O'Neill, Barbara J. Kidon, Burkhard Jansen
  • ALKOXYALKYL S-PRENYLTHIOSALICYLATES FOR TREATMENT OF CANCER
    Publication number: 20100189781
    Abstract: Disclosed are alkoxyalkyl S-prenylthiosalicylates and pharmaceutical compositions containing the same and a pharmaceutically acceptable carrier. Methods for treating a human afflicted with cancer, including solid tumors, or a hematological malignancy by administering to the human in need thereof an effective amount of an alkoxyalkyl S-prenylthiosalicylate are also disclosed.
    Type: Application
    Filed: January 20, 2010
    Publication date: July 29, 2010
    Applicants: RAMOT AT TEL-AVIV UNIVERSITY LTD., CONCORDIA PHARMACEUTICALS, INC.
    Inventors: Yoel Kloog, Liat Goldberg, Victor J. Bauer
  • Methods and Compositions for Oral Delivery of FTS
    Publication number: 20090226512
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Application
    Filed: August 18, 2005
    Publication date: September 10, 2009
    Applicant: Concordia Pharmaceuticals, Inc.
    Inventor: Victor J. Bauer
  • Method of tranquilizing and treating pain
    Patent number: 3985889
    Abstract: Novel substituted 1,3-dihydrospiro[isobenzofuran]s and methods of preparing the same are described. These compounds are useful as tranquilizers, analgetic agents and intermediates therefor.
    Type: Grant
    Filed: July 1, 1975
    Date of Patent: October 12, 1976
    Assignee: American Hoechst Corporation
    Inventors: Victor J. Bauer, Raymond W. Kosley, Jr.
  • 1,3-Dihydrospiro[isobenzofuran]s and derivatives thereof
    Patent number: 3962259
    Abstract: Novel substituted 1,3-dihydrospiro[isobenzofuran]s and methods of preparing the same are described. These compounds are useful as tranquilizers, analgetic agents and intermediates therefor.
    Type: Grant
    Filed: December 12, 1973
    Date of Patent: June 8, 1976
    Assignee: American Hoechst Corporation
    Inventors: Victor J. Bauer, Raymond W. Kosley, Jr.
  • Substituted 1,3-dihydrospiro(isobenzofuran)s
    Patent number: 3959475
    Abstract: Novel substituted 1,3-dihydrospiro[isobenzofuran]s and methods of preparing the same are described. These compounds are useful as antidepressants, tranquilizers, analgetic agents and intermediates therefor.
    Type: Grant
    Filed: September 3, 1974
    Date of Patent: May 25, 1976
    Assignee: American Hoechst Corporation
    Inventors: Victor J. Bauer, Raymond W. Kosley, Jr.
  • 3-Aminoalkyl-1,3-dihydro-3-phenylspiro[isobenzofurans]
    Patent number: 3957828
    Abstract: Substituted 3-aminoalkyl-1,3-dihydro-3-phenylspiro[isobenzofurans] possessing tranquilizing properties, and process for the preparation thereof are described.
    Type: Grant
    Filed: August 29, 1974
    Date of Patent: May 18, 1976
    Assignee: American Hoechst Corporation
    Inventors: Victor J. Bauer, Helen H. Ong